Researchers assessed the therapeutic equivalence of proposed biosimilar CT-P41 and reference denosumab for the treatment of postmenopausal osteoporosis.
It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...
the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...
The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...
Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov ... serve as diagnostic tools and potential targets for treatments. Drawing from a large database of ...
Osteoporosis is one of the common bone diseases resulted due to loss in bone mass. This disease starts developing when the body consumes more bone tissue than it produces; thus, this reduces the bone ...
Mohali: Dr Jogender Singh, a faculty member at the Indian Institute of Science Education and Research (IISER), Mohali, has been selected as a member o.
Osteoporosis is a common condition in which bone mineral density is reduced, increasing the risk of fractures. Treatment may involve medications, weight-bearing exercises, and lifestyle changes. Diet ...